Brief: ADC Therapeutics - Expected Cash Runway Into Mid-2025
07/11/2023 12:18
Nov 7 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS SA - EXPECTED CASH RUNWAY INTO MID-2025
* ADC THERAPEUTICS SA - CONTINUED DECREASE IN TOTAL
OPERATING
EXPENSES EXPECTED IN FULL YEAR 2023 AND 2024 AS COMPARED TO 2022
Source text for Eikon: ID:nGNX4c5y75
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview